Ferreira Soraia R C, Moisés Valdir A, Tavares Agostinho, Pacheco-Silva Alvaro
Division of Nephrology, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo-Escola Paulista de Medicina, São Paulo-SP, Brazil.
Transplantation. 2002 Dec 15;74(11):1580-7. doi: 10.1097/00007890-200212150-00016.
Cardiovascular disease is the leading cause of death in renal transplant recipients. The purpose of this study was to determine the effects of a successful renal transplantation on left ventricular morphology and function and on the 24-hr blood pressure profile.
Twenty-four patients with end-stage renal disease were prospectively studied by ambulatory blood pressure monitoring and echocardiography before and at 3, 6, and 12 months after renal transplantation. Patients were also analyzed according to their renal function after transplantation.
We observed a significant drop in the mean values of daytime and nocturnal systolic blood pressure and in the 24-hr systolic pressure load at 12 months after transplantation. The most frequent echocardiographic finding was left ventricular hypertrophy (LVH), for which the incidence decreased from 75% before transplantation to 52.1% at 12 months after transplantation (P = 0.125). There was a significant decrease in left ventricular dilatation, and systolic dysfunction normalized in all patients after 12 months. The variables that best independently predicted the decrease in LVH were serum creatinine levels and the 24-hr systolic pressure load as registered by ambulatory blood pressure monitoring at 12 months after transplantation. We observed significant decreases in left ventricular mass and left ventricular mass index in the group of patients who had adequate renal function, as compared with no changes in patients who did not.
Correction of the uremic state by renal transplantation leads to complete resolution of systolic dysfunction, regression of LVH, and improvement of left ventricular dilatation. In fact the reduction of LVH was dependent on adequate renal function and on a decrease in the systolic pressure levels.
心血管疾病是肾移植受者的主要死因。本研究的目的是确定成功的肾移植对左心室形态和功能以及24小时血压曲线的影响。
对24例终末期肾病患者在肾移植前以及移植后3个月、6个月和12个月进行动态血压监测和超声心动图前瞻性研究。还根据患者移植后的肾功能进行分析。
我们观察到移植后12个月时,日间和夜间收缩压的平均值以及24小时收缩压负荷显著下降。最常见的超声心动图表现是左心室肥厚(LVH),其发生率从移植前的75%降至移植后12个月时的52.1%(P = 0.125)。左心室扩张显著减少,所有患者在12个月后收缩功能恢复正常。最能独立预测LVH下降的变量是血清肌酐水平以及移植后12个月动态血压监测记录的24小时收缩压负荷。与肾功能未恢复的患者相比,我们观察到肾功能良好的患者组左心室质量和左心室质量指数显著下降。
通过肾移植纠正尿毒症状态可导致收缩功能障碍完全消退、LVH消退以及左心室扩张改善。事实上,LVH的减轻取决于足够的肾功能和收缩压水平的降低。